Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

10.350
+0.2302.27%
Volume:153.65M
Turnover:1.58B
Market Cap:119.25B
PE:25.69
High:10.540
Open:10.470
Low:10.120
Close:10.120
52wk High:11.630
52wk Low:4.215
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.76
T/O Rate:1.33%
Dividend:0.26
Dividend Rate:2.51%
EPS(LYR):0.403
ROE:10.83%
ROA:5.65%
PB:3.28
PE(LYR):25.69
PS:4.20

Loading ...

CSPC Pharmaceutical Group Stock Slides 1.1% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jul 04

BRIEF-CSPC Pharmaceutical Says Hydroxocobalamin Hydrochloride Injection Obtains Approval

Reuters
·
Jul 03

CSPC Pharmaceutical Gets Clinical Trial Nod for Methylmalonic Acidemia Drug in China

MT Newswires Live
·
Jul 03

CSPC Pharmaceutical Group Ltd. Secures Clinical Trial Approval in China for High-Concentration Hydroxocobalamin Hydrochloride Injection to Treat Methylmalonic Acidemia

Reuters
·
Jul 03

CSPC Pharmaceutical Group Stock Rallies 3.8% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 03

CSPC Pharmaceutical Group Stock Advances 3.1% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 02

Chinese Investors Dump Tencent, Xiaomi Shares as Rally Fizzles

Bloomberg
·
Jul 02

Ascletis Pharma Faces Third-Party Challenge Over U.S. Patent Validity in Post Grant Review

Reuters
·
Jun 30

CSPC Pharmaceutical Group Ltd. Announces Appointment of Ms. LI Quan to Nomination Committee

Reuters
·
Jun 27

CSPC Pharmaceutical Group Stock Falls 1.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jun 26

CSPC Pharmaceutical Group Expands Subsidiary Operations in China

Reuters
·
Jun 24

CSPC Pharmaceutical Group Ltd. Secures Drug Registration Approval for Meloxicam Injection (III) in China

Reuters
·
Jun 23

CSPC Pharmaceutical Group Ltd. Files Next Day Disclosure Return to HKEX: Announces 500,000 New Shares Issued at HKD 5.98

Reuters
·
Jun 20

Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$10.22 From HK$8.02, Keeps at Buy

MT Newswires Live
·
Jun 16

CSPC Pharmaceutical Set to Benefit From AstraZeneca Agreement -- Market Talk

Dow Jones
·
Jun 16

CSPC Pharmaceutical Group Signs Strategic Collaboration with AstraZeneca for Drug Discovery

Reuters
·
Jun 13

BRIEF-Astrazeneca Enters Collaboration Worth Up To $5.22 Bln With CSPC Pharmaceuticals

Reuters
·
Jun 13

BRIEF-Cspc Pharmaceutical's Sys6040 Obtains Clinical Trial Approval In U.S.

Reuters
·
Jun 10

CSPC Pharmaceutical Group Ltd. Receives U.S. FDA Approval for Clinical Trials of SYS6040 Antibody-Drug Conjugate Targeting Advanced Solid Tumors

Reuters
·
Jun 10

CSPC Pharmaceutical Gets China Nod for Registration of Anemia Drug

MT Newswires Live
·
Jun 05